Back to Agenda
Session 4, Track C: Pharmacovigilance Unleashed: Unlocking PV Best Practices through KPIs and Data Mining
Session Chair(s)
Mei Lam, BSN, RN
Canada PV Manager/Safety Regional Country Contact
Haleon, Canada
Vanessa Zapata
Associate Director, Regional Pharmacovigilance Officer
Merck Canada Inc., Canada
This game-changing session will unravel the secrets of effective key performance indicators (KPIs) and their powerful application in the realm of pharmacovigilance. Industry experts will provide a deep dive into innovative solutions that seamlessly support pharmacovigilance integration activities during company acquisitions and product in-licensing deal. Additionally, the session offers exclusive insights from a health agency perspective on KPIs, providing a comprehensive understanding of this critical aspect of pharmacovigilance.
Learning Objective : - Analyze the critical role of Key Performance Indicators (KPIs) in optimizing pharmacovigilance processes
-
Demonstrate the application of data mining techniques to uncover valuable insights and drive informed decision-making in pharmacovigilance activities
- Evaluate strategies for seamlessly integrating pharmacovigilance operations during company acquisitions and product in-licensing deals, aligning with industry best practices
Speaker(s)
Innovative Solutions to Support PV Integration Activities in Company Acquisitions and Product In-license Deals
Stephanie Stankiewicz, MBA
Merck Sharp & Dohme LLC, United States
Director, Drug Safety
Effective KPIs and their application in PV
Manar Hammood, MSc
Zenith PV, Canada, Canada
Founder and Director of PV Operations
Expedited Reporting Compliance – A Health Canada Inspector’s Perspective
Fadi Sader, PhD
Health Canada, Canada
Regional Regulatory Compliance and Enforcement Officer
Have an account?